|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| C07D 413/14 | (2006.01) | ||
| A61K 31/415 | (2006.01) | ||
| A61K 31/454 | (2006.01) | ||
| A61K 31/4709 | (2006.01) | ||
| A61K 31/497 | (2006.01) | ||
| A61K 31/506 | (2006.01) | ||
| C07D 231/14 | (2006.01) | ||
| C07D 401/06 | (2006.01) | ||
| C07D 401/10 | (2006.01) | ||
| C07D 403/10 | (2006.01) | ||
| C07D 409/14 | (2006.01) |
| (11) | Patento numeris | 3224256 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15804210.1 |
| Europos patento paraiškos padavimo data | 2015-11-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-10-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-07-03 |
| (46) | Apibrėžties vertimo paskelbimo data | 2019-09-25 |
| (86) | Numeris | PCT/GB2015/053615 |
| Data | 2015-11-26 |
| (87) | Numeris | WO 2016/083820 |
| Data | 2016-06-02 |
| (30) | Numeris | Data | Šalis |
| 201421083 | 2014-11-27 | GB |
| (72) |
DAVIE, Rebecca Louise, GB
EDWARDS, Hannah Joy, GB
EVANS, David Michael, GB
HODGSON, Simon Teanby, GB
|
| (73) |
Kalvista Pharmaceuticals Limited,
Porton Science Park Bybrook Road, Porton Down Wiltshire SP4 0BF,
GB
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | N-((het)arilmetil)-heteroarilkarboksamidų junginiai, kaip plazmos kalikreino inhibitoriai |
| N-((HET)ARYLMETHYL)-HETEROARYL-CARBOXAMIDES COMPOUNDS AS PLASMA KALLIKREIN INHIBITORS |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-10-21 | 11 | 289.00 EUR |
| 2026-11-26 |